SIGN UP
LOG IN
E
NVNO
Envveno Medical Corporation
3.52
0.21+6.50%Opening13:36 05/02 EDT
OPEN/PREV CLOSE3.400/3.310
TODAY RANGE3.290-3.728
VOL165.12K
MARKET CAP61.81M
52 WEEK RANGE2.028-6.48
AVG VOL (3M)88.74K
% TURNOVER0.94%
TURNOVER--
P/E (TTM)-2.7695
% RANGE13.24%
EPS(TTM)-1.2728
P/E(FORWARD)-2.8893
P/B1.466
BVPS2.404
DIVIDEND--
P/S73.99
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP61.16M
SHARES OUTSTANDING17.54M
NEXT EARNINGS07/29-08/04
FREE FLOAT17.35M
LOT SIZE1
EX-DIV DATE11/30/2020
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
enVVeno Medical reports Q1 results
TipRanks·1d ago
enVVeno Medical reports Q1 EPS (22c) vs. (31c) last year
Benzinga·04/17 12:09
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·04/17 08:59
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Seeking Alpha·03/03 08:44
enVVeno Medical reports Q4 results
TipRanks·02/28 22:30
enVVeno Medical files $100M mixed securities shelf
Reuters·02/28 22:29
ENVVENO MEDICAL CORP FILES FOR MIXED SHELF OF UP TO $100 MLN - SEC FILING
TipRanks·02/28 13:22
enVVeno Medical reports FY24 EPS ($1.27) vs. ($1.91) last year
TipRanks·02/28 13:21
enVVeno Medical expects capital to fund company through several milestones
TipRanks·02/19 13:50
enVVeno Medical presents one-year data from VenoValve trial
TipRanks·02/07 14:05
enVVeno Medical presents two-year follow-up data from VenoValve trial
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.